Drawing for BREATHEFREE

USPTO serial 99975376

BREATHEFREE

Reviewed by CopyMark Law Group

Status 649Office Action
Filing date
Status date
Registration date
—
Examiner
KOLODNER, LOUIS FRANCIS
Law office
TMO LAW OFFICE 122

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Need help with BREATHEFREE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nila K. Jackson

Nila K. Jackson Law Office of Nila Kay JacksonP.O. Box 802Front Royal, VA 22630United States

Goods and services

ClassDescriptionStatusFirst use
005Cough and congestion suppressing mullein leaf gummies and dropsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Oct 9, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Aug 25, 2026GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Aug 25, 2026GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Aug 25, 2026CNCFACTION CONTINUING A FINAL - COMPLETED—
Jul 10, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jul 10, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 10, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 29, 2026DPCCDIVISIONAL PROCESSING COMPLETE—
May 5, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 11, 2026DRRRDIVISIONAL REQUEST RECEIVED—
Apr 11, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 11, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 11, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2026ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Jan 13, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 12, 2026DOCKASSIGNED TO EXAMINER—
Jan 2, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 26, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 26, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance